Recall archive / FDA drug enforcement
EPINEPHrine 4mg/250mL added to 0.9% sodium chloride, IV Bag, RX only, Central Admixture Pharmacy Services, Inc., 2200... — FDA record D-0954-2023
Reported terminated
Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.
Source date Jul 14, 2023. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
What the record says
- Product
- EPINEPHrine 4mg/250mL added to 0.9% sodium chloride, IV Bag, RX only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Phoenix, AZ 85043, NDC: 72196-8093-1.
- Reason
- Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
- Classification
- Class II
- Recalling firm
- Central Admixture Pharmacy Services, Inc.
- Quantity
- 9,121 bags
- Agency-reported status
- Terminated
- Source record identifier
- D-0954-2023
What the recall classes mean. Classification is an agency assessment, not individual medical advice.
Lot and product identifiers
| Label field | Details supplied by the agency |
|---|---|
| Lot, code or applicability | Lot: 36-239250, Exp. 7/10/2023; 36-240225, Exp.7/16/2023; 36-241268, 36-241270, Exp. 7/19/2023; 36-241443, Exp. 7/20/2023; 36-242436, 36-242439, Exp. 7/25/2023; 36-241443, Exp. 7/20/2023; 36-242436, 36-242439, Exp. 7/25/2023; 36-243517, 36-243738, Exp. 7/30/2023; 36-245656, Exp. 8/2/2023; 36-246154, 36-246169, 36-246672, 36-246673, 36-246674, Exp. 8/3/2023; 36-247015, 36-247016, 36-247017, Exp. 8/7/2023; 36-247339, 36-247341, 36-247342, 36-247343, Exp. 8/8/2023; 36-249466, 36-249467, Exp. 8/17/2023; 36-249591, 36-249592, Exp. 8/18/2023; 36-251338, Exp. 8/27/2023; 36-251940, Exp. 8/30/2023; 36-254371, 36-254372, 36-254373, 36-254375, Exp. 9/4/2023. |
Match all identifying details in the current notice. A brand name alone is not enough.
Distribution
Nationwide in the USA
States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.
- Alaska
- Alabama
- Arkansas
- Arizona
- California
- Colorado
- Connecticut
- Delaware
- Florida
- Georgia
- Hawaii
- Iowa
- Idaho
- Illinois
- Indiana
- Kansas
- Kentucky
- Louisiana
- Massachusetts
- Maryland
- Maine
- Michigan
- Minnesota
- Missouri
- Mississippi
- Montana
- North Carolina
- North Dakota
- Nebraska
- New Hampshire
- New Jersey
- New Mexico
- Nevada
- New York
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Virginia
- Vermont
- Washington
- Wisconsin
- West Virginia
- Wyoming
Dates in the source
- Report date
- Aug 9, 2023
- Recall initiation date
- Jul 14, 2023
- Center classification date
- Aug 1, 2023
- Termination date
- Mar 28, 2025
FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.